Congenital CataractNCT07778797
Guangke Lenses in Congenital Cataract
A study testing Conventional Bifocal Lenses and Individually Customized Bifocal + Defocus Lenses in people with Congenital Cataract, run by Eye & ENT Hospital of Fudan University at 1 site in China.
Trial summary
This study aims to investigate whether individually customized bifocal + defocus spectacles can slow myopic shift in children after congenital cataract surgery. Read more about this study
- Who is it for?
- Ages 4 to 12 years
- Conditions the study is for
- Congenital Cataract
- What is being tested?
- Conventional Bifocal Lenses and Individually Customized Bifocal + Defocus Lenses
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteChina
- Study dates
- 6 Aug 2025to 6 Aug 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 4 to 12 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Aged 4 to 12 years (inclusive) at the time of enrollment. Diagnosed with bilateral congenital cataracts. Has undergone bilateral cataract extraction with intraocular lens (IOL) implantation.
- Time since cataract surgery is between 1 to 6 months (inclusive) at the time of enrollment.
- Able to undergo regular ophthalmic examinations (including refraction, axial length measurement, and intraocular pressure assessment).
- Parent(s) or legal guardian(s) are willing and able to provide written informed consent.
Who cannot join
- Presence of any systemic disease (e.g., metabolic disorders, autoimmune diseases, genetic syndromes, etc.).
- Presence of any ocular disease other than congenital cataracts (e.g., glaucoma, uveitis, retinal disorders, corneal diseases, strabismus, amblyopia, etc.).
- Previous or current use of myopia control treatments, including but not limited to atropine eye drops, orthokeratology (Ortho-K) lenses, or other myopia control spectacle lenses.
- History of ocular trauma or intraocular surgery other than cataract extraction and IOL implantation.
- Known allergy or hypersensitivity to any materials or components used in the study lenses.
- Inability to comply with the study protocol or complete scheduled follow-up visits.
- Participation in another interventional clinical trial within the past 30 days.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
Eye & ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, 200031
Jin Yang, PhD, 13671632525, jin_er76@hotmail.com
About this study
Official title: Investigation of Guangke Lenses' Efficacy in Delaying Myopia Onset/Progression in Postoperative Congenital Cataract Children
This study aims to investigate whether individually customized bifocal + defocus spectacles can slow myopic shift in children after congenital cataract surgery.
Read the detailed description
Children with congenital cataract who have undergone surgery will be fitted with individually customized bifocal + defocus spectacles. Refraction and axial length will be monitored at regular intervals to assess the effect of the intervention on myopic progression.
- Conditions
- Congenital Cataract
- Being tested
- Conventional Bifocal Lenses, Individually Customized Bifocal + Defocus Lenses
- Keywords
- Photochromic Lenses, Congenital Cataract, Axial length, Myopic shift
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Conventional Bifocal LensesDevice
Standard conventional bifocal spectacles without peripheral defocus design.
Individually Customized Bifocal + Defocus LensesDevice
Individually customized bifocal spectacles with peripheral defocus design for myopia control.
| Study group | Role | What they receive |
|---|---|---|
| Active Comparator: Conventional Bifocal Lenses | Active comparator | Participants in this arm will wear conventional bifocal spectacles (without defocus design). Receives: Device: Conventional Bifocal Lenses |
| Experimental: Individually Customized Bifocal + Defocus Lenses | Experimental | Participants in this arm will wear individually customized bifocal spectacles with peripheral defocus design. Receives: Device: Individually Customized Bifocal + Defocus Lenses |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Axial Length (AL)
Change in axial length (in millimeters) from baseline measured by optical biometry.
Measured: Baseline to 12 months
Change in Spherical Equivalent Refraction (SER)
Change in spherical equivalent refraction (in diopters) measured by cycloplegic autorefraction from baseline.
Measured: Baseline to 12 months
Secondary outcomes (3)
Change in Corneal Curvature
Change in corneal curvature (in millimeters) measured by corneal topography.
Measured: Baseline to 12 months
Change in Intraocular Pressure (IOP)
Change in IOP (in mmHg) measured by non-contact tonometry.
Measured: Baseline to 12 months
Incidence of Adverse Events
Number of participants with ocular or systemic adverse events related to the study lenses.
Measured: Baseline to 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Aug 2026
- Study start6 Aug 2025
- Primary completion6 Aug 2028 (estimated)
- Study completion6 Aug 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Congenital CataractStudies of the same condition, open and under way.
- More trials run by Eye & ENT Hospital of Fudan UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Eye & ENT Hospital of Fudan University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jin Yang, Eye & ENT Hospital of Fudan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07778797
- Sponsor's protocol ID
- Guangke lenses_2025
- Status last verified
- Aug 2026
- First submitted
- 18 Aug 2026
- Last updated
- 21 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of Guangke Lenses' Efficacy in Delaying Myopia Onset/Progression in Postoperative Congenital Cataract Children
- ClinicalTrials.gov ID
- NCT07778797
- Acronym / sponsor ID
- Guangke lenses_2025
- Conditions
- Congenital Cataract
- Keywords
- Photochromic Lenses, Congenital Cataract, Axial length, Myopic shift
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Eye & ENT Hospital of Fudan UniversityUniversity, hospital or other
- Study start
- 6 Aug 2025 (actual)
- Primary completion
- 6 Aug 2028 (estimated)
- Study completion
- 6 Aug 2030 (estimated)
- First posted
- 21 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate whether individually customized bifocal + defocus spectacles can slow myopic shift in children after congenital cataract surgery.
Detailed description
Children with congenital cataract who have undergone surgery will be fitted with individually customized bifocal + defocus spectacles. Refraction and axial length will be monitored at regular intervals to assess the effect of the intervention on myopic progression.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Active Comparator: Conventional Bifocal Lenses | Active comparator | Device: Conventional Bifocal LensesParticipants in this arm will wear conventional bifocal spectacles (without defocus design). |
| Experimental: Individually Customized Bifocal + Defocus Lenses | Experimental | Device: Individually Customized Bifocal + Defocus LensesParticipants in this arm will wear individually customized bifocal spectacles with peripheral defocus design. |
Who may qualify
- Ages
- 4 to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- Aged 4 to 12 years (inclusive) at the time of enrollment. Diagnosed with bilateral congenital cataracts. Has undergone bilateral cataract extraction with intraocular lens (IOL) implantation.
- Time since cataract surgery is between 1 to 6 months (inclusive) at the time of enrollment.
- Able to undergo regular ophthalmic examinations (including refraction, axial length measurement, and intraocular pressure assessment).
- Parent(s) or legal guardian(s) are willing and able to provide written informed consent.
Key exclusion criteria (7 listed)
- Presence of any systemic disease (e.g., metabolic disorders, autoimmune diseases, genetic syndromes, etc.).
- Presence of any ocular disease other than congenital cataracts (e.g., glaucoma, uveitis, retinal disorders, corneal diseases, strabismus, amblyopia, etc.).
- Previous or current use of myopia control treatments, including but not limited to atropine eye drops, orthokeratology (Ortho-K) lenses, or other myopia control spectacle lenses.
- History of ocular trauma or intraocular surgery other than cataract extraction and IOL implantation.
- Known allergy or hypersensitivity to any materials or components used in the study lenses.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Conventional Bifocal LensesStandard conventional bifocal spectacles without peripheral defocus design. | Device | Active Comparator: Conventional Bifocal Lenses |
| Individually Customized Bifocal + Defocus LensesIndividually customized bifocal spectacles with peripheral defocus design for myopia control. | Device | Experimental: Individually Customized Bifocal + Defocus Lenses |
Primary outcome
Change in Axial Length (AL)
Time frame: Baseline to 12 months
Change in axial length (in millimeters) from baseline measured by optical biometry.
Change in Spherical Equivalent Refraction (SER)
Time frame: Baseline to 12 months
Change in spherical equivalent refraction (in diopters) measured by cycloplegic autorefraction from baseline.
3 secondary outcomes
Change in Corneal Curvature
Time frame: Baseline to 12 months
Change in Intraocular Pressure (IOP)
Time frame: Baseline to 12 months
Incidence of Adverse Events
Time frame: Baseline to 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2026.
Related trials for Congenital Cataract
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
Enrolling by invitationObservational study
The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy
Fuchs Endothelial Corneal Dystrophy, Cataract
Not yet recruiting
Partial Range Of Field IOLs in DMEK-Enabled Procedures
Cataract, Fuchs Endothelial Corneal Dystrophy
Not yet recruitingObservational study
Postoperative CCT in FECD vs. Non-FECD
Fuchs Endothelial Corneal Dystrophy, Cataract (Post-operative Cataract Surgery Follow-up)
Not yet recruiting
Augmented Reality Training for Amblyopia After Congenital Cataract Surgery
Deprivation Amblyopia, Congenital Cataract
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Conventional Bifocal Lenses and Individually Customized Bifocal + Defocus Lenses in people with Congenital Cataract, run by Eye & ENT Hospital of Fudan University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jin Yang, Dr. (021-64377134, jin_er76@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Axial Length (AL) (time frame: Baseline to 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.